Seeing Is Believing
Currently out of the existing stock ratings of Donald Ellis, 35 are a BUY (94.59%), 2 are a HOLD (5.41%).
Analyst Donald Ellis, carries an average stock price target met ratio of 46.46% that have a potential upside of 84.94% achieved within 334 days. Previously, Donald Ellis worked at JMP.
Donald Ellis’s has documented 72 price targets and ratings displayed on 8 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on CLSD, Clearside Biomedical at 21-Dec-2021.
Analyst best performing recommendations are on OCUL (OCULAR THERAPEUTIX).
The best stock recommendation documented was for OCUL (OCULAR THERAPEUTIX) at 11/12/2019. The price target of $7 was fulfilled within 113 days with a profit of $4.43 (172.37%) receiving and performance score of 15.25.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$16
$14.54 (995.89%)
23 days ago
(14-May-2025)
0/6 (0%)
$14.82 (1255.93%)
Buy
$9
$7.54 (516.44%)
28 days ago
(09-May-2025)
0/8 (0%)
$7.74 (614.29%)
Buy
$8
$6.54 (447.95%)
6 months 18 days ago
(19-Nov-2024)
0/3 (0%)
$3.41 (74.29%)
Buy
$7
$5.54 (379.45%)
6 months 18 days ago
(19-Nov-2024)
1/4 (25%)
$2.41 (52.51%)
315
Buy
$13
$11.54 (790.41%)
$2
6 months 19 days ago
(18-Nov-2024)
1/5 (20%)
$9.86 (314.01%)
354
What Year was the first public recommendation made by Donald Ellis?